# Montara Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/montara-therapeutics

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.montaratx.com
- Total disclosed funding: $28M
- Latest round: Seed (Feb 26, 2025)
- Investors on record: 5

## About

Based in California, US, and founded in 2022 by CEO Nicholas T. Hertz, PhD, Montara Therapeutics, Inc. operates as a precision-medicine biotech company that focuses on creating CNS disease medications using precision pharmacology, human genomics, and machine learning to enhance drug safety and effectiveness in neurological disorders. In January 2024, Montara Therapeutics, Inc. raised an amount of USD 8 million in venture funding from unspecified investors.

The company provides treatments for patients with central nervous system (CNS) conditions.

## Funding rounds

- Seed, Feb 26, 2025, $20M — SV Health Investors, Dolby Family Ventures, KdT Ventures, Two Bear Capital, BEVC
- Seed, Jan 5, 2024, $8M — SV Health Investors, Dolby Family Ventures, KdT Ventures, Two Bear Capital

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Seed
- Dolby Family Ventures (https://capitalatlas.ai/funds/dolby-family-ventures) — Seed
- KdT Ventures (https://capitalatlas.ai/funds/kdt-ventures) — Seed
- Two Bear Capital (https://capitalatlas.ai/funds/two-bear-capital) — Seed
- BEVC (https://capitalatlas.ai/funds/bevc) — Seed